You beauty! Adore Beauty share price soars 22%

The Adore Beauty share price is in catch-up mode following yesterday's market carnage.

| More on:
A happy beautiful woman with curly brown hair and wearing bright red lipstick smiles representing the soaring Adore Beauty share price today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Adore Beauty share price is soaring today, up 22% to $1.54
  • There has been no news announced by the online beauty retailer today 
  • The broader market is recovering from yesterday's carnage 

The Adore Beauty Group Ltd (ASX: ABY) share price is surging today, up 22.22% to $1.54.

The broader market is also on the rebound, with the S&P/ASX All Ordinaries Index (ASX: XAO) up 1.5% after a shocker of a session yesterday.

Is the Adore Beauty share price just playing catch-up?

There's been no news out of the online beauty retailer today. So, this mammoth gain may just be a case of catch-up following yesterday's carnage.

ASX shares were hammered yesterday. Investors around the world reacted with fear after higher than expected inflation numbers were released in the US. The All Ords lost 1.84% yesterday while the Adore Beauty share price shed 13.5%. So today, perhaps investors are seeing an opportunity to buy the dip.

Inflation is the key reason behind rising interest rates around the world. The Australian Reserve Bank raised the official cash rate for the first time since November 2020 earlier this month.

Rising interest rates mean people with mortgages are going to have less disposable income to spend. This is causing a bit of a rotation out of consumer discretionary shares like Adore Beauty. The S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) is down 2.6% over the past month and down 20% over the past six months.

Market volatility provides opportunity

When markets are volatile, Motley Fool Australia's Chief Investment Officer Scott Phillips says long-term investors need to grit their teeth and ride it out.

But big fluctuations in ASX share prices can also present buying opportunities. This is particularly so for investors interested in growth shares and micro and small caps with growing revenue, like Adore Beauty.

On 28 April, the online cosmetics retailer released its latest business update for Q3 FY22. It revealed a revenue gain of 9% on the prior corresponding period (pcp) to $42.7 million. Loyalty members contributed more than 60% of total revenue. Its compound annual growth rate (CAGR) is now 26%.

Active customer numbers increased 7% to 880,000 and returning customers increased 47% compared to the pcp. Plus, the company intends to launch a private label brand in the final quarter of FY22.

Broker's vote of confidence

Broker UBS likes Adore Beauty's continued operational growth and its prospects for future revenue growth. The broker says Adore Beauty shares are a buy with a 12-month price target of $4.70. That's a whopping potential upside of more than 200%.

Adore Beauty share price snapshot

The company's shares are down 63% this year to date and down 54% over the past 12 months.

Adore Beauty has a market capitalisation of $118 million with 91.4 million shares on issue.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Adore Beauty Group Limited. The Motley Fool Australia has recommended Adore Beauty Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Beef cattle in stockyard.
Consumer Staples & Discretionary Shares

Queensland floods to have a 'material' impact on this ASX agricultural stock's earnings

This company is likely to experience a material hit to earnings as a result of the floods in Queensland.

Read more »

A wine technician in overalls holds a glass of red wine up to the light and studies it.
Consumer Staples & Discretionary Shares

Treasury Wine shares keep the good times flowing

Brokers warn that the current lift is likely to be fragile.

Read more »

A man pushes a supermarket trolley with phone in hand down a supermarket aisle looking at the products on the shelves.
Consumer Staples & Discretionary Shares

Are Coles or Woolworths shares a better buy in 2026?

Which supermarket giant is the better buy this year?

Read more »

Young fruit picker clipping bunch of grapes in vineyard.
Consumer Staples & Discretionary Shares

Down over 50%, is this the ASX 200's greatest recovery share for 2026?

After a brutal year, Treasury Wine shares have been deeply sold off. Is a recovery starting to take shape for…

Read more »

A car dealer stands amid a selection of cars parked in a showroom.
Consumer Staples & Discretionary Shares

This ASX All Ords stock edges lower as investors digest key milestone

After completing a major acquisition, this ASX All Ords stock is back in focus as investors assess the next phase.

Read more »

A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.
Consumer Staples & Discretionary Shares

Why is Cobram Estate rocketing 17% today?

Cobram Estate shares jump 17% today after a broker upgrade and renewed confidence in its US growth plans.

Read more »

A young farnmer raise his arms to the sky as he stands in a lush field of wheat or farmland.
Consumer Staples & Discretionary Shares

These agricultural stocks are fundamentally undervalued, Bell Potter says

Bell Potter has named three stocks in the agricultural sector that it believes to be fundamentally undervalued.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Consumer Staples & Discretionary Shares

Why this ASX small-cap share is back in focus after a US market update

A fresh US update has put Bubs shares back on investors’ radars as FDA approval moves closer and sales continue.

Read more »